Engaging with CROs During Molecule Development

David Horton, director of Regulatory Affairs at Medpace, sits down with Xconomy Managing Editor Dan Stanton for a fireside chat at the June 11, 2020 Xcelerating Life Sciences Philadelphia conference to discuss the importance of early planning for biotechs, and why engaging with a CRO at the right time can bring advantages to the development of a molecule.